Self-reported everyday functioning among adults with human immunodeficiency virus: Longitudinal associations with global neurocognitive functioning and depressive symptoms.

Prescott MR, Paolillo EW, Rivera Saldana CD, Franklin D, Pasipanodya EC, Hussain MA, Moore RC, Heaton RK, Montoya JL, Moore DJ, HIV Neurobehavioral Research Program (HNRP) Group

Low-energy pathways lead to self-healing defects in CsPbBr(3).

Miskin K, Cao Y, Marland M, Shaikh F, Moore DT, Marohn JA, Clancy P

Prevalence trends and risk factors for allergic rhinoconjunctivitis, asthma and eczema in the UK.

Diwakar L, Subramanian A, Shah DK, Subramaniam S, Pelly VS, Greenfield S, Moore D, Nirantharakumar K

Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinoma.

Lee MS, Chao J, Mulcahy MF, Kasi PM, Alistar AT, Mukherjee S, Akce M, Moore DT, McRee AJ, Somasundaram A

Web surveys during the COVID-19 pandemic: a critical look for collective learning.

Moreira MCN, Abramov DM, Camacho KG, Junqueira-Marinho MF, Reis AT, Gomes Junior SCDS, Moore DCBC

Beyond total depressive symptoms: Differential associations between depressive domains, HIV status and disease characteristics.

Prescott M, Wang C, Gentry M, Franklin D, Stein MB, Atkinson JH, Ellis R, Heaton RK, Montoya J, Moore D, Iudicello J

Are pesticides the dominant stressors in German lowland streams?

Moore DRJ, Rathjens H

Sleep disruption in chronic rhinosinusitis improves using exhalation-delivery nasal steroid therapy.

Moore DL, Nolte R, Maharana S, Patel EA, Codispoti C, Batra PS, Mahdavinia M

Impacts of overdose and socio-structural factors on recent mortality among people with HIV in British Columbia, Canada.

Tam C, Zhang W, Moore D, Salters K, Trigg J, Wesseling T, Parashar S, McLinden T, Sereda P, McDougall P, Moher M, Montaner JSG, Hogg R, Barrios R

A systematic review and network meta-analysis of interventions to preserve insulin-secreting beta cell function in people newly diagnosed with type 1 diabetes: results from randomised controlled trials of immunomodulatory therapies.

Beese SE, Price MJ, Tomlinson C, Sharma P, Harris IM, Adriano A, Quinn LM, Gada R, Horgan TJ, Maggs F, Burrows M, Nirantharakumar K, Thomas GN, Andrews RC, Moore DJ, Narendran P

Examining effects of race and chronic rhinosinusitis on asthma; more evidence for unified-airway diseases.

Moore DL, Patel EA, Tajudeen BA, Batra PS, Mahdavinia M

Gaps, Successes, and Opportunities Related to Social Drivers of Health from the Perspectives of Black Preterm Infant Caregivers: A Qualitative Study.

Karvonen KL, Anunwah E, Gilmore S, Griffiths-Randolph U, Karvonen KA, Moore D, Miller K, Overall J, Wooten L, Afulani PA

Achieving equitable, timely and comprehensive biomarker testing for patients with NSCLC.

Navani N, Sharman A, Evison M, Shepherd P, Shah R, Moore DA

Subclonal immune evasion in non-small cell lung cancer.

Dijkstra KK, Vendramin R, Karagianni D, Witsen M, Gålvez-Cancino F, Hill MS, Foster KA, Barbè V, Angelova M, Hynds RE, Pearce DR, Martínez-Ruiz C, Black JRM, Huebner A, Pich O, Rowan A, Augustine M, Puttick C, Moore DA, Liu LL, Saghafinia S, van de Haar J, Veeriah S, Naceur-Lombardelli C, Toncheva A, Bola SK, Hiley CT, Jamal-Hanjani M, McGranahan N, Litchfield K, Reading JL, Chain B, TRACERx consortium, Quezada SA, Voest EE, Swanton C

Tuberculosis preventive therapy: scientific and ethical considerations for trials of ultra-short regimens.

Walker TM, Watson JA, Moore DAJ, Frick M, Jamrozik E